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Abstract
Over the past few decades, there has been growing
support for the idea that cancer needs an interdiscipli-
nary approach. Therefore, the international cancer
community has developed several strategies as outlined
in the WHO non-communicable diseases Action Plan
(which includes cancer control) as theWorld Health As-
sembly and the UICC World Cancer Declaration, which
both include primary prevention, early diagnosis, treat-
ment, and palliative care. This paper highlights experi-
ences/ideas in cancer control for international collabo-
rations between low, middle, and high income coun-
tries, including collaborations between the European
Union (EU) and African Union (AU) Member States, the
Latin-American and Caribbean countries, and the East-
ern Mediterranean countries. These proposals are pre-
sented within the context of the global vision on cancer
control set forth by WHO in partnership with the Inter-
national Union Against Cancer (UICC), in addition to is-
sues that should be considered for collaborations at the
global level: cancer survival (similar to the project CON-
CORD), cancer control for youth and adaptation of
Clinical Practice Guidelines. Since cancer control is giv-
en lower priority on the health agenda of low and mid-
dle income countries and is less represented in global
health efforts in those countries, EU and AU cancer
stakeholders are working to put cancer control on the
agenda of the EU-AU treaty for collaborations, and are
proposing to consider palliative care, population-based
cancer registration, and training and education focus-
ing on primary prevention as core tools. A Community
of Practice, such as the Third International Cancer Con-
trol Congress (ICCC-3), is an ideal place to share new
proposals, learn from other experiences, and formulate
new ideas. The aim of the ICCC-3 is to foster new inter-
national collaborations to promote cancer control ac-
tions in low and middle income countries. The develop-
ment of supranational collaborations has been hin-
dered by the fact that cancer control is not part of the
objectives of the Millennium Development Goals (MG-
Gs). As a consequence, less resources of development
aids are allocated to control NCDs including cancer.
1. Introduction
According to WHO’s estimates global cancer deaths
will increase from 7.6 million in 2004, with 70 percent of
these cases occurring in low and middle income coun-
tries1. In 2007, the estimated 7.9 million deaths con-
tribute by 13% to the total death world wide2.
While the total cancer burden remains at high level in
resource-rich countries, it is increasing rapidly in re-
source-poor countries3. These trends reflect the preva-
lence and growth of cancer risk factors, and increasing
life expectancy at birth. Life expectancy at birth in
countries undergoing rapid economic development
(China, India, Brazil, etc.) has increased dramatically,
and these countries are now experiencing a cancer epi-
demic, as has already happened in the industrialized
world3.
Cancer is considered one of themain health problems
in the richest countries around the world. The impact of
the disease in most of these countries is demonstrated
by the strong relationship between cancer statistics and
socioeconomic indicators, such as per capita Gross Do-
mestic Product4,5. As a consequence, cancer is now one
of themost common health problems globally. The total
number of deaths from cancer globally is comparable to
the combined mortality from HIV/AIDS, tuberculosis
and malaria6.
Over the past few decades, there has been growing
support for the idea that cancer needs an interdiscipli-
nary approach and a global strategic vision, including
primary prevention, early diagnosis, treatment, and pal-
liative care, an approach universally known as “Cancer
Control”7,8. There is already international promotion
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and guidance of cancer control9 exchange through the
organization of Communities of Practice (CoP)10. CoP
are defined as groups of people who share a concern, a
set of problems, or a passion about a topic and who
deepen their knowledge and expertise in this area by in-
teracting on an ongoing basis10.Whether they are called
networks, alliances or communities, these groups exist
because there are individuals who appreciate the bene-
fits of collaboration on shared concerns. People in-
volved in CoP meet when they find value in their inter-
actions. They get to know one another, share informa-
tion, insights and advice, help each other to solve prob-
lems, discuss their situations, their aspirations and their
needs. They consider common issues, explore ideas,
and act in consequence. They create tools, standards,
generic designs, manuals and other documents and
work towards a common understanding of the issues.
CoP participants are motivated by the value they find in
communicating, learning and working together.
The third International Cancer Control Congress (IC-
CC-3)11 scheduled for November 2009 in Cernobbio,
Italy, will continue the work initiated at ICCC-1 in Van-
couver, Canada, in 2005 and furthered at the second IC-
CC in Rio de Janeiro, Brazil, in 2007, in building com-
munities of practice. The principal goals of the ICCC-3
are to reinforce global communities of practice through
extensive participation and dialogue between countries
and societies with different experiences in cancer con-
trol, by building on and supporting ongoing work by
governments, civil society, Non-Governmental Organi-
zations (NGO), and international organizations, and to
make sustainable cancer control an important global
priority. The theme of the third Congress is “Interna-
tional Collaboration between High Income and
Low/Middle Income Countries to achieve Population-
based Cancer Control”.
The present paper was prepared for the congress to
showcase some experiences of current international col-
laborations around cancer control and proposals for fu-
ture international collaborations in specific regions of
the world, including the European Union and African
Union Member States, Latin American and Caribbean
countries, and Eastern Mediterranean countries. These
regional proposals are presented within the context of
the global cancer control strategies proposed byWHO in
partnership with the International Union Against Can-
cer (UICC), as well as some new themes that should be
targeted in international collaborations at a global level,
including cancer control among youth andClinical Prac-
tice Guidelines. A discussion will also be presented
around efforts to promote and develop supranational
collaborations, which are hampered by low priority giv-
en to cancer control by international development agen-
cies as well as within national health planning and re-
source allocation in low and middle income countries.
2. Building the collaboration between the
European Union and African Union
The goal of the Africa Health Strategy (2007-2015),
which was signed by all Members of the African Union
in Addis Ababa in 2007, is to contribute to Africa’s socio-
economic development by improving the health of its
people and by ensuring access to essential health care
for all Africans, especially the poorest and most margin-
alized, by 201512. Many countries in Africa are con-
fronting particular challenges in meeting the targets of
the Millennium Development Goals (MDGs)* by 201513,
and will require a broad range of strengthened efforts to
meet those targets. Such efforts must include effective
action to tackle the shortfalls in policy, predictable fi-
nancing, data collection and implementation capaci-
ties.
Worsening protein energy and micronutrient malnu-
trition in many countries continues to contribute to el-
evated mortality. About 60% of under-five mortality in
some parts of Africa is attributable to malnutrition,
which remains a major challenge to development and
child survival in Africa12. HIV/AIDS, tuberculosis and
malaria pose the greatest challenges in the African
Health Strategy 2007-201512.
The African Union (AU) is committed to quality
healthcare delivery strategies for the continent that pro-
mote universal access for every African nomatter the ge-
ographical location or stage in life. The AU will continue
to work with Member States to ensure that every African
receives the best quality and timely health services.
In 2008, the AU Commission and the EU Commission
adopted a declaration to intensify continent-to-
continent policy dialogue, cooperation and joint action
at all levels, with the goal of achieving the MDGs in all
African countries14.
By 2020, more than 1 million of the cancer cases in re-
source-poor countries will come from Sub-Saharan
Africa15. Determining health priorities and allocating re-
sources are national decisions. In Africa, as in other low
and middle income countries (LMCs), these decisions
are deeply influenced by the priorities of the “Global
Health Community”.
Cancer control is given lower priority on the health
agendas of LMCs and less represented in global health
efforts in those countries. African countries, of all the re-
source-poor countries, are the least able to cope with
the coming cancer epidemic. To address these chal-
lenges there is a need to16: a) ensure equitable access to
* The United Nations Millennium Development Goals (MDG),
signed in September 2000, are goals that all 191 member states have
agreed to try to achieve by the year 2015. The Eight MDGs are: to erad-
icate extreme poverty and hunger; to achieve universal primary educa-
tion; to promote gender equality and empower women; to reduce child
mortality; to improve maternal health; to combat HIV/AIDS, malaria,
and other diseases; to ensure environmental sustainability; and to de-
velop a global partnership for development.
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2.1. On domains where the AU-EU collaboration
might be implemented
Faith Mwangi-Powell
Palliative care should be a critical component of over-
all national cancer control programs in Africa – both as
a vehicle for delivering health promotion messages, and
as a means of alleviating pain and other troubling
symptoms – and should be integrated into other cancer
prevention, early detection and treatment strategies.
However, palliative care has been neglected on the con-
tinent, overshadowed by donor funding prioritization
and compartmentalization of communicable diseases,
especially HIV/AIDS. The challenges associated with
palliative care service provision for cancer patients in
Africa are considerable and are evident at four levels of
the health care system: the socio-cultural context level;
the governmental, legalistic and national context level;
the service provider level; and the service user level.
Nevertheless, practitioners on the continent have
demonstrated an ability to advance palliative care un-
der favorable conditions, and we expect similar ad-
vances to be made in the field of cancer.
Cancer is a national health priority in the European
Union and in general in theWest. In Africa, cancer is as
prevalent as in the West, but goes largely untreated, as
other diseases are currently prioritized by governments
and donors where funds are limited. In resource-rich
countries: 1) people with cancer are recognized by pro-
fessionals to be in need of treatment, 2) patients per-
ceive their need for care, and 3) services are generally
available. People with cancer occupy the overlapping
intersection of these three domains. In sub-Saharan
Africa, professionals are only now starting to identify
cancer as a public health issue; there is still little patient
demand for cancer treatment in rural areas and medical
services are severely limited. Health priorities in Africa
in the last 25 years have understandably focused around
maternal and child health, TB, leprosy, malaria and
more recently HIV/AIDS. Measures to prevent and early
detect cancer, which are emphasized in the industrial-
ized world – such as smoking cessation and screening –
are not yet nationally adopted, although the WHO re-
gional office has recently adopted a regional cancer
control strategy19.
National Cancer registries are the only means to pro-
vide valid data on cancer incidence, which is essential
for cancer control planning. However, there are only
very few cancer registries in the African region covering
approximately 11% of the population20.
The gap of services for cancer patients in particular in
rural African is critical and depends much on the med-
ical infrastructure, referral systems to secondary and
tertiary cancer and reimbursement policies.
Africa would like to engage in international collabora-
tions. In order to promote collaboration with the Euro-
pean Union, the experiences and suggestions for inter-
health and education services; b) provide encourage-
ment to and assistance with adopting and ratifying the
WHO Framework Convention on Tobacco Control; c)
provide resources to implement cancer surveillance,
prevention, detection, diagnosis, treatment and pallia-
tive care; d) ensure low-cost access to essential drugs
and life-saving interventions; e) support education and
training for existing and new healthcare workers; f) un-
dertake awareness raising campaigns about cancer; g)
invest extensively to support improvements in infra-
structure and equipment; h) support access to up-to-
date medical literature from a range of top peer-re-
viewed journals; and i) support research collaborations
with resource-rich countries.
There are few cancer intelligence units in Africa at the
moment and those that do exist invariably suffer from
lack of funds and do not cover enough of the population
to allow reliable extrapolation of data for the whole
country. Cancer registries also form a useful framework
for evidence-based cancer research and, therefore, the
lack of such resources is undermining research capacity
within African nations15.
There is a need to promote a series of collaborations
between the EU and AU, following the adopted declara-
tion14 to intensify continent-to-continent policy dia-
logue, cooperation and joint action at all levels, with the
goal of achieving theMDGs in all African countries. Col-
laborative programs addressing the present and future
needs in cancer control should be fostered, in line with
the recommendations of the MDG (Goal number 8),
which encourage re-commitment to the ODA (Official
Developed Assistance) pledge of 0.15-0.20 percent of
the Gross National Income (GNI) to Less Developed
Countries (LCDs) included in the Action Plan for
LCDs17, and the 2005 G8 Gleneagles summit commit-
ment to double aid to Africa from $25 billion in 2004 to
$50 billion by 201017.
This EU-AU collaboration should be based on the Eu-
ropean experience in collaborating on efforts to control
cancer and on the state of situation in Africa. Four do-
mains should be taken into consideration: for the pres-
ent needs, palliative care; for present and future needs,
training and education (focusing on primary preven-
tion); cancer research; and promoting control and can-
cer surveillance by developing cancer registries.
Within these domains connections should be made
with the main experts and stakeholders: collaborations
should be fostered with cancer patients and volunteer
associations to better understand the importance of
palliative care; there should be constant cooperation
with the European School of Oncology18 to build train-
ing projects across Europe; research should be conduct-
ed to generate new knowledge about the basic nature of
cancer, and about new and more effective approaches
to primary prevention, diagnosis and therapy, and the
European cancer registries should be actively involved
in projects.
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national collaboration, such as those that follow, should
be considered under the umbrella of the EU-AU treaty.
This collaboration should emphasize and address the
fact that cancer is a growing and considerable threat on
the African continent. Consequently, palliative care
should be a critical component of overall national can-
cer control programs and should be integrated into oth-
er cancer control strategies.
However, the reality of finite national budgets and the
myriad social, political, legislative and other challenges
to effective service provision mean that individual sub-
Saharan nations cannot address cancer in isolation. The
EU-AU collaboration is a new cooperative approach
that is advocating for the prevention, treatment and pal-
liation of cancer in countries of the AU, and is a means
to bridge the gap between resource-rich and resource-
poor nations. In this regard, EU countries should work
in partnership with resource-poor African countries,
encouraging governments to develop cancer control
programs and helping them to address the challenges
that hinder the implementation of palliative care servic-
es for cancer patients.
2.2. Pap smear diagnosis via satellite for Africa
APOF board (Rosario Tumino, Vincenzo Stracca Pansa,
Agostino Faravelli, Paolo Giovenali, Laura Viberti,
Tiziano Zanino), Paolo Marelli
The Italian NGO “APOF” (Associazione Patologi Oltre
Frontiera) was established in the year 2000 for the cre-
ation or the improvement of histopathology depart-
ments in low income countries.Western countries ben-
efit from thousands of specialists who work in the field
of anatomical pathology. On the other hand in sub-Sa-
haran Africa, for instance, this service is absent or relies
on a very small number of pathologists. This is why in
Cuba, Egypt, Djibouti, Kosovo, Madagascar, Palestine,
Tanzania, Uganda and Zambia, APOF is involved in
projects that use a tele-pathology system to address the
lack of pathologists.
APOF is aware that one of the crucial problems is the
prevention of cervical cancer, one of the primary causes
of death from cancer for women in south-western
Africa21, a large region heavily affected by the lack of
personnel qualified to read pap-tests.
In 2005, with a pilot project in the village of Chirundu,
in southern Zambia, a histo-lab was built and two
young local technicians were trained by Italian volun-
teers who travelled to Chirundu. After the training, the
two technicians were able to screen Pap’s smears, sepa-
rating the negative cases from positive ones. In addi-
tion, they learnt to prepare samples embedded in paraf-
fin blocks and histological sections both from biopsies
and surgical specimens. Digital photographs were taken
of the suspicious or positive cases and sent to a group of
nearly 100 volunteer reviewers, one of whom is on
monthly rotation and responsible for final diagnosis.
For the histological diagnoses a digital scanner was
used with a satellite connection. An organized group of
volunteer pathologists confirmed the histological diag-
nosis within four days after scanning the case. Every six
months all the histological and cytological slides were
sent to Italy and verified. Preliminary results of this ex-
perience, including cost evaluation, are satisfactory.
2.3. Psychosocial morbidity and quality of life in
cancer patients: the Southern European psycho-
oncology study - an international collaboration at
the EU level
Luigi Grassi, Luzia Travado, Francisco Gil
Psycho-oncology literature has demonstrated 25-35%
prevalence of emotional disorders among cancer pa-
tients, but only aminority of patients correctly identified
by oncologists. Training models have shown to increase
doctors’ confidence in their skills to address patient's
needs. In Southern European countries (e.g., Italy, Spain,
Portugal) data are lacking and a study conducted in
these 3 countries aimed to: (i) examine psychosocial
problems secondary to cancer; (ii) rate the extent of its
recognition by oncologists; (iii) develop and apply a
training model to improve doctors’ ability in detecting
psychological disorders in their patients. A series of can-
cer outpatients were evaluated as regards to theirmental
status (WHO-ICD-10), psychological morbidity (HADS),
coping strategies (Mini-MAC), concerns about illness
(CWI), and ability to talk with their family (Openness
scale). Doctors and a subgroup of patients completed al-
so, independently, a VAS relative to quality of life issues.
Doctors were asked to complete questionnaires (Self-
Confidence in Communication Skills and Expected Out-
come of Communication) about their confidence in
communicating and dealing with emotions of cancer
patients. A specifically designed training model was de-
veloped and applied to doctors participating in patients’
assessment phase. 277 patients participated in the study.
One third (33.08%) had pathological scores (“borderline
cases” plus “true cases”) on HAD-Anxiety and 24.81% on
HAD-Depression. “Caseness” related to high scores on
CWI, low scores on Openness, high scores on Hopeless-
ness and Anxious Preoccupations of Mini-MAC22. Con-
cordance between doctors (n = 39) and patients on qual-
ity of life domains was within 27-43% range. Levels of
doctors’ confidence in their ability to deal with emotions
in cancer patients were in mild range23. The training
model was applied to doctors (n = 30), satisfaction was
high and confidence in their skills significantly im-
proved24. This International multicentre study proved to
be a successful way to network and conduct research in
countries with similar cultural backgrounds25-27.
2.4. A community work model for a cancer survivor
driven support network in South Africa
Linda Estelle Greeff, Strydom Eldre
In order to assess the need for service and set up a
support service for newly diagnosed cancer patients
with different kinds of cancer we began a pilot project in
Cape Town, South Africa. This program was developed
with the full support and assistance of Ann Steyn, the
current National Chairperson of Reach for Recovery In-
ternationally. During the implementation process is-
sues with logistics were encountered, and strategies for
getting such a project started and functional needed to
be devised.We established screening criteria for choos-
ing cancer survivors that would be suitable for receiving
supportive counseling and information about newly di-
agnosed patients. We developed a training program for
the Cancer Buddies to prepare them for the task of sup-
porting newly diagnosed cancer patients, and set up a
system to provide continuous supervision, training and
support for these cancer buddies as they rendered sup-
port services to the new patients they visit.
The model for this pilot project provides a workable
model for setting up a peer-to-peer counseling and sup-
port network that can be used in many different com-
munities. It is especially applicable in resource-poor re-
gions where trained professional support services are
lacking and expensive and exclusive modalities of care
are not feasible. This is not a newmodel but an adaption
based on the very successful peer supportmodel “Reach
for Recovery” which is supported by the UICC and has
been implemented for breast cancer all over the world.
The sharing of best practice models of care in the field
of psycho-oncology is of great importance as we seek to
develop more effective ways of providing support not
only to breast cancer survivors but also to patients diag-
nosed with other cancers. Further evaluation of this
project will determine its effectiveness and its value in
the cancer community for application in other contexts
of care.
2.5. Cancer survival in Eastern Libya: preliminary
data from the Benghazi Cancer Registry
Mufid El Mistiri, Nadia El Sahli, Mohamed El Mangush,
Adel Attia, Rehab Shembesh, Hanna El Arafi,
Amina El Faidi
Background So far, few and scattered data are avail-
able on cancer incidence and mortality in Northern
Africa. The Benghazi Cancer Registry (BCR) was estab-
lished in 2002 under the auspices of the National Re-
search Centre; in the year 2004 a twinning with Modena
Cancer Registry (MCR), Modena, Italy, was activated,
and the staff of MCR contributed to the training of
clerks in coding techniques and software use. So far the
BCR has already collected data for cases registered in
the years 2003-2004, thus allowing the assessment of
cancer survival in Benghazi municipality.
Methods All incident cases of invasive cancer regis-
tered by the Benghazi Cancer Registry during 2003-2004
in the Benghazi area were selected for survival analysis.
The information abstracted from the registry includes:
id code, date of birth, residence, date of diagnosis, can-
cer sites classified according to the ICDO-3, date of last
contact and status at last contact. A check of records on
vital status is performed by active follow-up procedure,
including collecting information from all death registra-
tion offices and a search of hospital records. Relative
survival, an estimator of the excess risk of death, or the
excess mortality ratio, will be calculated by dividing the
survival observed in cancer patients by the survival that
would be expected in the general population of the
same age and gender (the probability of death by age
and gender will be taken from Libya life tables pub-
lished byWHO).
Results A total of 1,082 cases of invasive cancers were
recorded among residents in the Benghazi municipality
for the 2-year period 2003-2004. The most frequently di-
agnosed malignancies in males were lung (23.3%) and
colorectal cancer (10.2%), followed by bladder cancer
(9.3%). In women, breast cancer was the leading cancer
site (27.2%), followed by cancer of the colon and rectum
(9.9%), uterus (6.0%) and non-Hodgkin lymphoma
(5.6%). Of the cases, 581 (53.8%) were known to have
died. The top cause of cancer death was lung cancer in
males and breast cancer in women.
3. Cancer control collaboration in Latin
American and Caribbean countries
Following the 1st ICCC in Vancouver, Canada in 2005,
efforts to foster the formation of a global community of
practice included a proposal to establish the organiza-
tion of a regional process within the next two years, with
defined goals and actions for a Latin American and
Caribbean Alliance for Comprehensive Cancer Control,
through which collaboration and synergy could en-
hance cancer prevention and cancer care interventions
for individuals and populations.
In order to achieve its central aims, the Alliance had
expected to establish collaborative efforts among the
countries in order to share ideas and experiences of
common interest, including projects, studies, research
and national experiences in improving evidence-based
management, accreditation strategies, and assessment
and incorporation of new treatment breakthroughs and
technology for cancer control.
The Latin American and Caribbean Alliance for Com-
prehensive Cancer Control was developed in consulta-
tion with representatives from theWHO, the Pan-Amer-
ican Health Organization (PAHO) and leading national
and international organizations for cancer control, in-
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cluding access to political leaders and financial re-
sources essential to its goals and actions.
Signatories to the Rio de Janeiro Declaration in 200728
committed themselves to mobilizing their colleagues
and governments to support the Latin American and
Caribbean Alliance for Comprehensive Cancer Control
and as initial priorities, support the work plan of the
Ibero-American Network on Tobacco Control and the
adoption of an action plan for cervical cancer control.
In the past two years, the Latin American-Caribbean
regional, bilateral, multi-national and cross-regional
collaboration has made progress and has had many ac-
complishments as well as many challenges. Further dis-
cussions will determine how best to promote cancer
control in Latin American and Caribbean countries and
move forward with the next phase of the Alliance.
3.1. Breast cancer control in Brazil
Carla Andréia Vilanova Marques, Maria Gaby Rivero de
Gutiérrez, Elisabeth Niglio de Figueiredo
In comparison to other cancer malignancies, breast
cancer has the highest incidence rates amongwomen in
Brazil both in terms of morbidity and mortality. The im-
pact of the disease has required Governmental Control
Interventions by Public Programs28,29. These programs
are described in several documents that need to be eval-
uated in order to understand the strategy.We investigat-
ed, in a chronological order, which strategies were used
during the development of National Breast Cancer Con-
trol Program. The National Health System database was
searched for documents from a narrative review per-
spective, using the keywords: cancer control, cancer
programs and women’s health. Ten documents were re-
trieved and analyzed. The National Institute of Cancer
was created in 1957, and the first National Program in
Breast Cancer started in 199830,31. The strategies imple-
mented before 2004 focused on breast self-examina-
tion, education, cancer treatment, and reconstructive
breast surgery. After 2004, the Breast Cancer Control
Consensus began, with goals directed towards primary
care through education in heath promotion and early
detection, identification of target groups, opportunistic
screening, and qualification of mammography servic-
es32. In 2005, the National High Complexity Oncology
Structure for treatment was developed by the National
Oncology Politic33. Currently, the network system in
breast cancer is beginning a pilot project to implement
a systematic breast cancer screening program. The proj-
ect was developed with help and advice from other re-
source-challenged countries. Although previous strate-
gies have focused on treatment and education, this ini-
tiative will focus on early detection. The long road to
this point has been influenced by the economic situa-
tion in Brazil and the geographic constraints of imple-
menting strategies over such a large area. Despite the
different strategies implemented in the past 10 years,
the Brazilian Breast Cancer Strategies has improved and
is moving forward.
3.2. Medicine consumption and spending for
chemotherapy of the most prevalent tumors in Brazil
Tereza Maria Piccinini Feitosa, Reinhard Braun,
Isis Tomasini
Background In Brazil, cancer is a public health prob-
lem and the Brazilian Universal Health System (SUS) is
the main financier of the National Cancer Control Pro-
gram. The National Cancer Institute (INCA) of the
Health Ministry implements the National Oncology
Health Care Policy33-35 and monitors the cancer treat-
ment costs in order to plan the appropriate allocation of
resources by the government36. In this context, the in-
vestigation of chemotherapy spending is a key element
for decision-making costs.
Objective To present the spending on chemotherapy
medicines per patient in INCA, for the most prevalent
tumors (lung, prostate, breast cancer, cervical cancer,
colon/rectum).
Methods We identified the operational data system
containing information on the acquisition, prescrip-
tion, manipulation and administration of chemothera-
py.We developed a management tool to capture the ex-
isting operational data for continuous monitoring and
analysis of the spending, in order to assist SUS in man-
aging the consumption of chemotherapy medicines.We
investigated spending from a sample of 3,163 patients
for the year 2008.
Result The total spending for chemotherapymedicines
and the average cost per patient for the following tumors
were, respectively: Lung (US$ 152,860.61; US$ 499.54);
Prostate (US$ 95,686.10; US$ 885.98); Breast (US$
3,838,303.08; US$ 1,937.56); Cervical (US$ 61,976.96; US$
180.69); and Colon/rectum (US$ 159,829.63; US$ 376.07).
Discussion The development and use of the manage-
ment tool permitted a global visualization of the spend-
ing per patient for each type of cancer. Moreover, the
tool facilitated the monitoring of expenditure on
chemotherapy medicines for the following areas: Plan-
ning; Supplies; Clinical Oncology; and Pharmacy. How-
ever, there is a possibility for improvement in this man-
agement tool in order to obtain more data on the fol-
lowing expenditure allocations: hospital support mate-
rials; out-sourced services; and Human Resources.
4. Cancer control experiences
and collaborations in the Eastern
Mediterranean area
In the Eastern Mediterranean (EM) region, cancer is
the fourth most common cause of death and is increas-
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ingly recognized as a major health concern. According
toWHO projections, cancer incidence in the EM area is
expected to increase from 0.5 million cases in 2008 to
0.9 million cases in 20303. In the EM region, most coun-
tries still lack reliable population based data and can-
cer is not covered by regular surveillance, so identifica-
tion of intervention priorities for cancer prevention is
extremely difficult. As noted by some scientists in the
region, where data do exist, poor reporting regulations
and practices affect their quality and reduce their use-
fulness. Furthermore, good data are often poorly used
due to the poor connection between the production of
knowledge (academia) and its consumption (policy
makers and the general public). The failure of invest-
ment in preventive and primary care programs and ac-
tions has led to health care being taken over by market
forces with a curative, rather than preventive, orienta-
tion. This has led to disparities in access to health care
and the widespread distribution of risk factors for dis-
ease. The most frequent tumor types in the Eastern
Mediterranean area are breast carcinoma in women
and lung and bladder cancers in men1. The WHO Re-
gional Office, in association with the Princess Lalla
Salma Association against Cancer (HRH Princess Lalla
Salma), non-governmental organizations and other rel-
evant international organizations in the Region, agreed
to establish an alliance against cancer to join forces in
order to generate an appropriate and concerted effort
to prevent and control cancer. The alliance was created
in Marrakech in 2007, under the patronage of HRH
Princess Lalla Salma, and a secretariat based in Moroc-
co was established. Membership in the alliance will be
open to all organizations active in the field of cancer in
the Region and also for prominent individuals37. An-
other alliance, the Middle East Cancer Consortium
(MECC)38,39 was established through an official agree-
ment between the Ministries of Health of Cyprus,
Egypt, Israel, Jordan, and the Palestinian Authority. The
agreement was signed in Geneva in 1996. Turkey offi-
cially joined the Consortium in 2004. The objective of
theMECC is to reduce the incidence and impact of can-
cer in the Middle East through the solicitation and sup-
port of collaborative research. Since its inception,
MECC’s major activities have focused on the Cancer
Registry Project (CRP), which supports population-
based cancer registries within MECC members and de-
velops linkages between them, and the Small Grants
Program, which provides funding for clinicians and sci-
entists withinMECC signatories. All proposals for fund-
ing are peer-reviewed for their scientific merit and
must involve collaboration between more than one
participating MECC member. In addition to its flagship
activities, MECC is involved in efforts to enhance can-
cer communications, control cancer, and improve pal-
liative care and end-of life services for patients with
cancer.
4.1. A model for international and regional scientific
collaborations in the King Hussein Cancer Center
Jamal Khader
The King Hussein Cancer Center (KHCC) is known to
be a leading comprehensive Cancer Center in the Mid-
dle East region. KHCC has been working extensively on
realizing its mission of providing state-of-the art com-
prehensive cancer care to the citizens of Jordan and the
region. In order to do so, KHCC has relied heavily on
creating, maintaining and strengthening its bilateral In-
ternational Scientific Collaboration with some of the
best cancer centers in the world40.
KHCC has built a strong and functional relationship
with the University of Texas, MD Anderson Cancer Cen-
ter and with the National Cancer Institute in Cairo,
Egypt over the past few years. Activities, such as faculty
visits, staff training, medical professional observer
workshops and participation in International Sympo-
siums, have all opened the doors for even bigger and
better opportunities for each centre. As part of M.D. An-
derson’s Cancer Center (MDACC) Global Academic Pro-
grams, KHCC now plays a significant role in Jordan and
the region. Inviting professionals from MDACC to con-
duct intensive workshops for local physicians and tech-
nicians has also proven to have a great impact on the
level and quality of services provided at the centers41.
Similar to the activities with MDACC, the relationship
with NCI-Cairo is vital in connecting the pillars of cancer
care in the region. Areas of collaboration between the
centers are complimentary to each institution’s mission
and vision, especially in oncology nursing, pediatric on-
cology, palliative and hospice care, and cancer registries.
4.2. Initiating a psychosocial treatment program for
cancer patient’s in Turkey
Patricia Fobair, Haldun Soygur, Derya Akbiyik
Physicians from Turkey and a Fulbright Social Work
Senior Specialist (2007-2012) from California collabo-
rated in 2008 to develop a psychosocial treatment pro-
gram for cancer patients at the Ankara Oncology Educa-
tion and Research Hospital. The team met in 2006 at an
international oncology meeting in Venice, Italy. Drs.
Haldun Soygur and Derya Akbiyik invited Patricia
Fobair to speak at a successful 180 participant work-
shop for Turkish oncology health professionals in Cap-
padocia in 2007. Enthusiasm for the concept of devel-
oping a psychosocial treatment program for cancer pa-
tients in Turkey led to further collaboration resulting in
Grant ID 88413989, Project ID 3263 by Fulbright 2008:
Develop the Psychosocial Treatment Program for Can-
cer Patients at the Ankara Oncology Research andTrain-
ing Hospital, Turkey in 2008.
Using a public health planning process we developed
goals for the program, after learning from the patients
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and staff about patient needs and concerns; we re-
viewed the ideas presented for practical implementa-
tion; chose several ‘best ideas’ for presentation to the
administration for implementation; gained the assis-
tance needed (time, budget, personnel) and organized
for implementation of a pilot program, testing the ideas’
usefulness. Evaluating results of the pilot test, alter-
ations were made for the new program.
Goals were accomplished: two weeks for the survey;
two weeks initiating group interventions; and two
weeks evaluation and discussion of future plans.
During the six weeks between November 10-Decem-
ber 22, the Soygur, Akbiyik and Fobair team-mates suc-
ceeded in demonstrating that cancer patients needed
additional services, that staff was available and interest-
ed in providing group support and occupational thera-
py services, and that medical faculty, the Director of the
Hospital, andHealthMinister were supportive of initiat-
ing a Supportive Care Program at the Ankara Oncology
hospital as a model for the country.
The work of initiating a Supportive Care Program in
Ankara continues. A proposal will be written to the
Health Ministry applying for continuing funds for a So-
cial Work staff position. Additional grants will be sub-
mitted to the World Health Organization and the Euro-
pean Union for funds allowing collaboration for the
program’s growth throughout the country. In the mean-
time, the psycho-education groups started for the
breast cancer patients and men with testicular cancer
continue with Turkish health professionals leading the
groups. The Occupational therapy, art classes began in
February 2009, a program for group singing is the most
recent addition to the program.
Collaboration between health faculties in countries of
diverse ethnic and religious origins were effective in this
US-Turkish collaboration. It is increasingly possible for
such collaborations to occur, depending only on affini-
ty and commonality of purpose and need. As an inter-
national organization, Fulbright can take credit for set-
ting the stage where new friendships among health pro-
fessionals concerned with cancer can meet, confer and
begin relationships that can lead to improved health
care programs for cancer patients.
The authors are grateful for the assistance from the
Fulbright Senior Specialist Program (US State Depart-
ment) which underwrote the consultant's expenses dur-
ing the six weeks in Ankara, Turkey. The Ankara Oncolo-
gy Research andTrainingHospital in Ankara,Turkey pro-
vided the housing and maintenance expenses.
This model of collaboration between health faculties,
between countries of diverse ethnic and religious ori-
gins can be effective. It is possible for collaborations to
occur, when affinity and commonality of purpose are
discovered. As an international organization, IPOS can
take credit for setting the stage where new friendships
among health professionals concerned with cancer
meet, and begin relationships that lead to improved
health care programs for cancer patients throughout
the world.
We demonstrated that by using a planning process,
we could involve the patients and staff in supporting the
development of a new program.With continuous meet-
ings with the staff and patients, we were able to counter
resistances and provide successful group interventions
for the patients. In the future, as the program grows pa-
tients will participate in providing clinical research in-
formation that will allow for more sophisticated pro-
gram evaluation. At the moment, increasing patient
participation and staff enthusiasm speak to the pro-
gram's success.
5. Cancer control: the World Cancer Declaration
promoted by UICC
The UICC8 is an international non-governmental or-
ganization dedicated exclusively to the global control of
cancer. It is a dynamic global community of connected
cancer control organizations, professionals and volun-
teers working together to eliminate cancer as a major
life-threatening disease for future generations. Their
mission is to connect, mobilize and support cancer or-
ganizations and individuals with knowledge and skills
to increase their effectiveness. The main objectives of
theUICC are to develop,maintain and continuously im-
prove knowledge and transfer platforms for communi-
cation and mutual support; establish/enhance the au-
thority of UICC through key knowledge transfer “flag-
ship” activities; build international capacity for cancer
control, by promoting collaboration and partnerships
across sectors and geographical divides; use the collec-
tive voice of UICC to advocate globally for cancer con-
trol as a public health priority and for achieving the
achievable; provide resources and “umbrella” support
for coordinated activities that complement activities of
member organizations for the populations they serve.
Since 2005, the UICC has promoted yearly world can-
cer campaigns focused principally on prevention (pri-
mary and secondary) and improving childhood habits,
and since 2006, UICC has coordinated World Cancer
Day activities. The global vision promoted in 2009 by
the UICC is synthesized in the World Cancer Declara-
tion42 signed the 26th of August 2009 by 649 institutions
and 9082 individuals, which outlines a plan of action to
reduce the global cancer burden by 2020 and increase
cancer's visibility on the international political agenda.
In Geneva, the 58thWorld Health Assembly accepted a
resolution urging Member States among other things:
• “to collaborate with the Organization in developing
and reinforcing comprehensive cancer control pro-
grams tailored to the socioeconomic context...”;
• “to set priorities based on national burden of cancer,
resource availability and health system capacity for
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cancer prevention, control and palliative-care pro-
grams”;
• “to integrate national cancer-control programs in ex-
isting health systems...”.
Although this resolution is of historical importance,
this by no means will ensure that governments will
comply with what was adopted by their representatives
on the 25th of May 2005 in Geneva.
In this respect, the example of the WHO Framework
Convention on Tobacco Control has been somewhat
sobering: it has recently been shown that tobacco lob-
bies have succeeded in blocking the requested national
legislation in most resource-poor countries. One of the
main approaches for putting pressure on governments
to act according to theWHO resolution is tomount pub-
lic pressure in each country. In order to achieve this
task, NGOs and the UICC in particular, are probably the
most important resource for mobilizing civil society.
UICC now encompasses 330 member organizations
in 103 countries and is therefore the most important
global NGO in the field to fight against cancer. At the
2008 World Cancer Congress (WCC) in Geneva, an up-
dated World Cancer Declaration was approved, which
requests urgent action on the following issues:
• availability of cancer-control plans in all countries;
• substantial improvement in the measurement of the
global cancer burden;
• substantial decrease in tobacco consumption, obesi-
ty, and alcohol intake;
• universal vaccination in areas affected by Human Pa-
pilloma Virus and hepatitis B virus;
• misconceptions about cancer dispelled;
• substantial improvements in early detection pro-
grams;
• diagnosis and access to cancer treatment, including
palliative care, improved worldwide;
• effective pain control universally available;
• greatly improved training opportunities in oncology;
• substantial decrease in migration of health workers;
• major improvement in cancer survival in all coun-
tries.
The followings projects illustrate the strategies that
are being used to realize these targets in regions with
differing levels of available resources.
5.1. Results of a comparison between 10 national
cancer plans (NCPs) in Europe
Renèe Otter, Jean Francois Doré, Josep Maria Borras, José
Expósito Hernandez, John Fitzpatrick, Brigitte Guillemette,
Niels Hermann, Tony Holohan, Jozsef Lövely, Teresa Moss,
Reto Obrist
Background NCPs are essential in prioritizing the key
actions necessary in the country to reduce cancer inci-
dence and mortality. To identify whether a coordination
of NCPs on a European levelmight reinforce the EU goal
of reducing the burden of cancer, a comparison of the
NCPs was done in the European+Plus Project in 2007.
ObjectivesThrough analysis of similarities, differences
in goals, contents, and priorities, the leaders of the
NCPs can weigh the additional relevance of a coordina-
tion (of some aspects) of NCPs at the EU level in order to
more rapidly achieve the national goals of the NCP.
Methods The study was carried out by identifying the
existing NCPs at the end of 2006; determining their will-
ingness to participate; preparing a general questionnaire,
based on the NCCP and policies (managerial guidelines
of WHO and UICC publication on NCCPs); and organiz-
ing meetings to validate the results/conclusions.
ResultsTen regional-national plans from8different EU
countries were analyzed. The plans included domains of
primary prevention, screening, and care (medical, sup-
portive, psychosocial and palliative). Research, training
of professionals, patient education, and information
were not covered by all plans. Concerning screening,
there was a diversity regarding the methods used, the
age range of invited persons and the interval period cho-
sen. Not all countries focused on national/regional treat-
ment guidelines, implementation of clinical pathways,
multidisciplinary teams or rehabilitation programs, al-
though all participants reported that they would like to
incorporate these aspects into their plans. A coordinat-
ing group at the EU level should support and advise the
development and implementation of a NCP, and super-
vise the integration of domains and scientific evidence
within the NCPs. At the EU level, a monitoring instru-
ment for a NCP should be available to make consistent
and comparable monitoring and evaluation possible.
Conclusions A coordinating group at the EU level
would improve the implementation of NCPs and speed
up the realization of the main goal of the NCP: to reduce
the burden of cancer. A framework for information ex-
change according to different domains, which should
be part of a NCP, will be part of such an EU program.
5.2. The 1st international tele-health palliative care
symposium
Judith Salmon Kaur, Christine DeCourtney, Melanie
Merriman
As the incidence and prevalence of chronic diseases
and cancer increase worldwide, there is a critical need
to develop resources for palliative care43,44. The Mayo
Clinic and the Alaska Native Tribal Health Consortium
piloted a “virtual" symposium on palliative care. The
symposium involved the US, Canada, Australia, New
Zealand and American Samoa. Social Networking tools
such as Facebook, Twitter, LinkedIn and Flickr allowed
registrants from around the world to connect to lectures
and to post questions for speakers in real-time and to
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“discuss” issues with other participants. Over 390 par-
ticipants logged in to hear speakers address a wide
range of palliative care topics, from cultural perspec-
tives to pain and other symptom management. Many
sites held face to face sessions in their locale or discus-
sion groups to complement the formal presentations.
We are creating an ongoing “virtual” palliative care
community so that teams can share the latest informa-
tion and resources, discuss their local palliative care
needs, submit questions to experts on theWeb and sup-
port each other beyond the formal conference. At Mayo
Clinic, Rochester, MN, 10 teams of professionals from
across the Indian Health Service participated in experi-
ential training in the Medical Simulation Center and
made hospital rounds with hospice and palliative care
professionals each morning and participated with the
teleconference in the afternoons. This intensive case-
based palliative care training involved both “hands on”
and didactic sessions.
This symposium was unique for the breadth of na-
tions and locations represented and the use of cutting-
edge technology to bring people together. The results of
the online evaluation of this conference will help to plan
for our 2010 conference and may help to identify op-
portunities for participation from other countries.
5.3. Survivors: living through and beyond cancer: an
Italian study on rehabilitation for cancer patients
Lucia Mangone, Massimo Vicentini, Carlotta Pellegri,
Sonia Cilia, Maria Antonietta Orengo, Paolo Crosignani,
Mario Budroni, Fulvio Aurora, Francesco de Lorenzo,
Giovani Fattore, Milena Sant, Gemma Gatta, Francesca
Di Salvo, Paolo Baili, Andrea Micheli
Background The proportion of prevalent cases (per-
sons alive on a given date with a past or current cancer
experience) in Europe is estimated to be 1-3% of the
general population and >10% of the population 65+
years of age. Therefore the role of rehabilitation services
in cancer control is expected to increase. According to
our estimates, prevalent cases should total about 2 mil-
lion in Italy in 2010. CaReMoRe (Cancer Registry Model
on Rehabilitation) is a three-year Italian project that ex-
amines physical, psychological, nutritional and social
aspects of rehabilitation in order to provide indicators
useful for rehabilitation planning.
Methods Information on 1,800 cases (breast, colon, rec-
tum and lymphoma) provided by five Cancer Registries,
representing three different socio-demographic areas in
Italy, will be collected and analyzed. Two approaches are
planned: a cohort approach (cases diagnosed in 2002 and
followed up until 2007) and a period approach (cases di-
agnosed in 1997-2001 and studied in 2007).
Results In the first year, the Joint Community, consist-
ing of oncologists, epidemiologists, and cancer patient
organizations, identified indicators of current rehabili-
tation services, including physical (physiotherapy, re-
construction and complications for breast cancer;
stoma, urinary and sexual dysfunction for colorectal
cancer); nutritional (information and assistance); psy-
chological (type and duration of assistance); and social
(disability benefits and home care) indicators. For
breast cancer, indicators of direct (diagnostic and ther-
apeutic tests) and indirect (job loss, demotion and de-
creased/lost wages) costs were also identified.
Conclusions This will be the first time this kind of in-
formation is collected in Italy. Subsequently, we hope to
expand this project to other countries by seeking further
international collaboration so that we can build a
world-wide map of rehabilitation service use and re-
quirement. The results, disaggregated by disease severi-
ty and geographical area, may help policymakers plan a
budget to develop national rehabilitation services that
ensure that cancer survivorship requirements are met
adequately and equally.
6. World-wide study of cancer survival
(CONCORD); an example of international
collaboration
Michel P Coleman
The CONCORD study was originally intended to up-
date the first trans-atlantic comparison of cancer survival
(published in 1964) to the 1990s. Other countries rapidly
joined and it has become the first study to provide com-
parable estimates of cancer survival from many coun-
tries45. It revealedwide international variation in survival,
and confirmed the wide gap in survival between blacks
and whites across the USA. CONCORD brings together
data from 101 population-based registries in 31 coun-
tries. For 16 countries, the data covered the entire nation-
al population. For other countries, one or more regional
cancer registries provided data with national coverage
from around 1% to 60%45. In all, the base population was
almost 300 million. CONCORD presents 5-year relative
survival estimates for cancers of the breast (women),
colon, rectum and prostate based on almost 2 million
cancer patients fromaround theworld.The patientswere
diagnosed between 1990 and 1994 and followed until
1999. Survival estimates were adjusted for the wide inter-
national differences in backgroundmortality and for age.
Comparability of the estimates was maximized by cen-
tralized quality control with standard criteria, correction
of faulty records and a single, centralized analysis45. Some
2,800 complete (single-year-of-age) life tables by sex,
country/region, year and (in the USA) race were con-
structed to control for background mortality45,46. Esti-
mates were age-standardizedwith the International Can-
cer Survival Standard weights47. The highest survival was
seen in the USA (breast and prostate cancer), Japan
(colon and rectal cancers in men) and France (colon and
rectal cancers in women). The lowest survival for each
cancer in both sexes was seen in Algeria. In Australia and
Canada, survival was high and regional variations were
very small, suggesting widespread access to high stan-
dards of health care. In stark contrast, variation between
European countries and US states was apparent45. Plans
are in hand to update CONCORD to 2007, and extend it
to additional cancers and other countries. Problems of
funding, co-ordination and dissemination in such stud-
ies should be considered.
7. Cancer control experiences and
collaborations on the epidemiology of cancer
in young adults
Although less than 1% of all cancers are diagnosed in
the age class 15-24 years, they have a number of charac-
teristics that increase their impact on society: a) the
prevalence of adults diagnosed with cancer before the
age of 25 is increasing due to improving survival, and to a
lesser extent, increasing cancer incidence; b) the risk of
second cancers is high in adults surviving cancer diag-
nosed before the age of 25; c) many cancer survivors di-
agnosed before the age of 25 experience sequelae in later
life that require medical treatment; d) populations differ
markedly in cancer survival, implying inequality of ac-
cess to treatment for diseases in young people which are
typically highly curable; e) survival in adolescents/young
adults (AYA) is worse than in children with biologically
similar cancers, probably because intensive treatment
protocols have been mainly developed for children48-57.
The organization of care in AYA is ofmajor interest, be-
cause this group of patients is in between childhood and
adulthood. Without specific protocols available for AYA,
a closer collaboration between pediatric and general on-
cologists is required for the tumors occurring in AYA.
7.1. Cancer survival differences between European
adolescents (15-19 years) and young adults
(20-24 years)
Giulia Zigon, Gemma Gatta, Guido Pastore, Andrea Ferrari,
Annalisa Trama
ObjectivesTo compare the survival rates between ado-
lescents (15-19 years) and young adults (20-24 years)
with cancer diagnosed in Europe during 1995-2002.
Materials and methods Data from 83 population-
based cancer registries in 23 European countries in-
volved in EUROCARE-4 were analyzed. 30,187 AYA with
cancer diagnosed during 1995–2002 and followed-up to
December, 2003 were included in the analysis. Cancers
in AYA were classified using both ICCC (International
Childhood Cancer Classification) and ICDO-3 (Interna-
tional Classification of Disease for Oncology, 3rd ver-
sion). Five-year survival rates and 95% confidence inter-
vals were calculated and are shown in Table 1.
Conclusions Survival rates in young adults are worse
than in adolescents in most of the cancer sites, particu-
larly for leukemia and central nervous system tumors.
The disparities between AYA and children52 are also
large, likely due to the lack of specific protocols for AYA,
while the observed differences between adolescents
and young adults are likely due to themore frequent use
of the children’s intensive treatment protocols in the
adolescent group.
7.2. Adolescent cancer in El Salvador
Roberto Franklin Vasquez, Miguel Edgaro Bonilla,
Francesca Favini
The incidence and outcome of childhood cancer in
high income countries (HIC) is well documented, and
there is emerging information from low income coun-
tries (LIC). Among adolescents, equivalent incidence
and outcome data continue to show distinctive varia-
tions between different world regions and ethnic
groups. Based on the 2007 national census, which in-
cluded patients registered in the Pediatric Oncology
Network Data Base (POND), and the Surveillance Epi-
demiology and End Results (SEER) Program incidence
estimates for this age group58, we estimated the adoles-
cent cancer incidence for that year. One hundred seven-
ty-six new patients with cancer aged 0-14 years were di-
agnosed in 2007 (96 Acute Leukemias, 19 Central Nerv-
ous System Tumors, 11 Hodgkins Lymphoma, 9 Non-
Hodgkins Lymphomas, 5 Wilms’ Tumors, 3 Neuroblas-
tomas, 5 Retinoblastomas, 7 Soft Tissue Sarcomas, 8
Bone Tumors, 13 other diagnosis); representing 76.5 %
(176/230) of the expected cases for a population of
1,946,967. Additionally, during the same period, only 2
new patients between the ages of 15 and 19 years, of 121
cases expected in a population of 600,565, were admit-
ted in the pediatric cancer program.
In El Salvador, children aged 0-14 years, but not those
aged 15-19 years, are experiencing the benefits of being
treated for cancer in a pediatric setting. Although two
thirds of adolescents with cancer usually have a pediatric
type of disease, only a limited number of adolescents are
treated in the referral pediatric oncology unit; most of
them are treated by adult oncologists with no adequate
expertise in treating pediatric cancer. These data confirm
the necessity of cooperative action between adult and
pediatric oncologists to implement a referral system to
offer the best treatment for this group of patients.
7.3. Adolescent cancer in Guatemala
Federico Guillermo Antillon-Klussman,
Mauricio Castellanos, Patricia Valverde, Claudia Garrido,
Francesca Favini, Ronald Barr, Andrea Ferrari
Background Adolescents with cancer in resource-rich
countries are in a “gray zone” between Pediatric Oncol-
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ogy and Adult oncology, and are rarely included in clin-
ical trials. In resource-poor countries the situation
might be worse, with most patients lacking access to
care; however, little research has been done in this age
group.
Methods We analyzed the situation in Guatemala, fo-
cusing on the referral pattern at the Unidad Nacional de
Oncologlia Pediatrica (UNOP) in Guatemala City, the
only pediatric cancer referral centre in the country,
whose mission is to treat patients up to 18 years. In
2008, the population of children (0-14 years) was 5.78
million, and that of adolescents (15-19 years) was 1.5
million (total Guatemalan population 13.7 million).
Results Applying the cancer incidence derived from
the North-America Surveillance Epidemiology and End
Results (SEER) dataset59, we estimated that we would
expect 809 cases in the range 0-14 years, and 304 in the
range 15-19 years per year. In 2008, we treated 267 chil-
dren (observed/expected [O/E] ratio: 30%) and only 18
adolescents (O/E: 6%).
Conclusions Though two thirds of adolescents have
cancer subtypes typical of pediatric oncology, only 6%
of them are treated at UNOP.We believe most are treat-
ed by adult oncologists or have no access to care. Inter-
national collaboration can improve this situation. More
active cooperation with adult medical oncologists may
be required.
8. Cancer Control: international collaboration
on clinical practice guidelines (CPGs)
Susan O’Reilly
Evidence-based clinical practice guidelines are the
foundation upon which we build access to high quality
cancer control.The scope of guidelines spans prevention,
screening, diagnosis, treatment and symptom control.
Guideline development requires, as a minimum, a
critical mass of health professionals with enough time
and resources to develop guidelines that are not only
soundly based on appropriately conducted, well-de-
signed clinical trials, but are also tailored to meet the
needs of the population served and the competing goals
of provision of various social services, including health
care, in the political and fiscal realities in different coun-
tries or regions.
In circumstances where health care human resources
are insufficient to support buy-in and development of na-
tional or local guidelines, cancer systems and staff arewell
advised to adopt and adapt guidelines developed by re-
spected national or professional bodies in other coun-
tries. Examples comprise the National Institute of Clinical
Excellence (NICE) guidelines advice in the United King-
dom, the Cochrane Collaboration, the National Compre-
hensive Cancer Network (NCCN) or the American Society
of Clinical Oncology in the USA. A variety of European,
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Table 1 - Five-year survival (%) of European adolescents (15-19 years) and young adults (20-24 years) diagnosed during 1995-
2002 with cancers characteristics of this age group
Diagnostic group Five-year survival Five-year survival
(95% CI) (95% CI)
15-19 years 20-24 years
ICCC II(a) Hodgkin lymphomas 93.6 92.0 - 95.1 94.5 93.1 - 95.8
ICCC II(b) Non-Hodgkin lymphomas 70.9 66.3 - 75.5 75.1 71.3 - 78.8
ICCC I(a) Lymphoid leukaemias 55.6 50.2 - 61.0 44.8 38.5 - 51.2
ICCC I(b) Acute myeloid leukaemias 52.7 45.7 - 59.7 47.2 39.8 - 54.6
ICCC X(c) Germ cell: ovary 94.3 89.5 - 99.0 93.4 88.3 - 98.6
ICCC X(c) Germ cell: testis 91.9 89.3 - 94.5 95.0 93.8 - 96.1
ICDO-3 C440-C449* Melanoma of Skin 93.9 91.5 - 96.3 91.9 89.9 - 94.0
ICDO-3 C71* Brain 65.0 60.2 - 69.8 58.6 54.1 - 63.1
ICCC III(b) Astrocytomas 62.7 56.0 - 69.5 51.7 45.4 - 58.0
ICDO-3 C40-C41* Bone 59.1 54.7 - 63.6 62.2 55.6 - 68.7
ICCC VIII(a) Osteosarcomas 61.1 54.9 - 67.3 58.1§ 47.3 - 68.8
ICCC VIII(c) Ewing tumor 44.0 35.1 - 52.9 41.8 32.3 - 51.4
ICDO-3 C739* Thyroid carcinomas 99.5 98.8 – 100 99.6 99.3 - 99.9
ICCC IX Soft tissue sarcomas 64.7 59.6 - 69.8 62.6 57.8 - 67.3
ICDO-3 C53* Cervix 82.8§ 66.5 - 99.0 87.6 82.2 - 93.0
ICCC X(d) Ovary carcinoma 88.1§ 78.9 - 97.4 85.5 79.6 - 91.4
ICDO-3 C18* Colon 89.8 84.7 - 94.8 82.0§ 77.2 - 88.3
ICDO-3 C500-C509* Breast 84.1§ 73.1 - 95.0 80.4 75.2 - 85.7
ICDO-3 C339-C340* Lung 74.7§ 61.0 - 88.3 69.4 59.5 - 79.3
*Morphology-Melanoma of Skin: 8720-8790; brain: excluding 9530-9539 and 9590-9989; bone, thyroid, cervix, colon, breast: excluding 9590-
9989; lung: excluding 9590-9989 and 9050-9055.
§No cases diagnosed from Eastern Europe (the final survival value is calculated as the weighted sum of Northern Europe, UK and Ireland, Cen-
tral Europe and Southern Europe).
ICCC, International Childhood Cancer Classification.
ICDO-3, International Classification of Disease for Oncology, 3rd version.
Canadian and Australian practice guidelines are also
available. Countries may adopt the guidelines that are
best fitted to their means. The adaptation processes,
which typically limit access to those therapies or tech-
nologies demonstrating the greatest benefit or most cost-
effective intervention, are likeliest to be endorsed.
The Guidelines Workshop at the ICCC-3 will focus on
international collaboration in the adaptation of guide-
lines and their integration into the broader base of can-
cer care planning, oncology drug delivery, accessibility
and good fiscal management.
8.1. Patient self management for women with breast
cancer
Siew-Yim Loh, Cheng Har Yip, Ann Passmore
Patient self management is recognized as a crucial
part of medical care for chronic diseases60-62, but it has
yet to make an impact in the field of oncology. The aim
of this study was to explore, develop and evaluate a 4-
week self management program for women with breast
cancer.
The study design was guided by the complex inter-
vention framework63 to ensure maximum clinical evi-
dence. Starting from the preclinical phase, a qualitative
focus group (n = 39) for needs assessment was conduct-
ed, to inform the design of a self management program
for women with breast cancer64,65. The program was pi-
lot-tested (n = 6) and refined, and then evaluated using
a clinical controlled trial (n = 147). The primary end-
points were quality of life, participation in life, and psy-
chological distress (depression, anxiety and stress). The
secondary endpoints were cancer specific self efficacy
and proactive coping.
An intent-to-treat analysis using multivariate covari-
ance showed significant differences between the exper-
imental group and control group for limitation in So-
cial-Relationship participation (P = 0.015), Stress (P =
0.001), Anxiety (P = 0.003) and Depression (P = 0.003).
Significant differences between groups was also found
in the Cancer Self-efficacy scales (P <0.001 to P <0.002)
as well as in Proactive Coping (P <0.001). Bonferroni
corrections were applied on all analyses.
There should be more national as well as internation-
al collaboration to develop and promote innovative pro-
grams like the 4-week ‘SAMA’ program (Staying Abreast,
Moving Ahead), and to explore their potential for en-
abling women to self manage their breast cancer and
minimizing the range of breast cancer implications on
women’s quality of life. Strategies to reduce health care
utilization should be the focus, as breast cancer is
emerging as a new chronic illness, due to earlier detec-
tion and better treatment. Patient self management
programs may offer a viable option for cancer-care and
cancer-control strategies.
8.2. Bridging the gap – linking cancer management
with cancer care: the role of the oncology social
worker in South Africa
Clare Manicom
Introduction South Africa has several major health
care concerns aside from cancer control. Add to this the
reality of limited resources, and access to cancer treat-
ment becomes difficult for many. The provision of psy-
chosocial support for patients is therefore almost im-
possible outside of the private sector.
ObjectivesThis descriptive overview of the contrasting
and various roles of Oncology Social Workers in South
Africa illustrates the valuable contribution this group of
professionals can make to the Psycho-Social care of pa-
tients and their families by providing support and re-
spect for the patient as a whole person.
Materials andmethodsDatawas gathered frompersonal
interactions, correspondences and experiences of Oncolo-
gy SocialWorkers in various settings. Some of the competi-
tion for social workers’ energy and attention in various
healthcare settingswasexamined.This competitioncanbe
considered in categories of broader health care concerns,
existing social problems, and structural or policy obstacles.
The tasksandrolesundertakenbyOncologySocialWorkers
werealso reviewed, illustrating theneed for this group tobe
flexible, innovative and adaptable in the face of challenges.
Results Interdisciplinary sharing, as well as network-
ing nationally and internationally were beneficial for
social workers – all of these linkages can bring together
social workers who may feel isolated in their work. The
practices and approaches that are helpful and relevant
in South Africa were noted.
Conclusion It would be easy to allow daily challenges
and frustrations to overwhelm the average practitioner.
However, with support, acknowledgement and the re-
spect of clients, colleagues and authorities, it remains
within the power of South African oncology social work-
ers to make a meaningful contribution to the overall
well-being of cancer patients.
9. Conclusions: ideas for future cancer control
international collaborations
A Community of Practice10, such as the ICCC-3, is an
ideal place to share new proposals, learn from other ex-
periences, and formulate new ideas. The aim of the IC-
CC-3 is to create the basis for new international collab-
orations in order to promote cancer control actions in
LMCs. We have formulated some ideas for the EU-AU
future cancer control collaborations that can be also be
considered at the global level.
Palliative care
Late diagnosis of most cancers in LMCs and a lack of
treatment options even when diagnosis is early mean
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that there are large numbers of patients who can bene-
fit from palliative care in this region. The cornerstone of
palliative care is pain control with oral morphine or oth-
er strong opioid analgesics. These medications are
largely unavailable in LMCs. In addition to medication,
palliative care involves a range of other services to re-
lieve and manage symptoms and to provide psychoso-
cial support to patients and families in the communities
where they live. The two major obstacles to palliative
care in LMCs are (1) legal, societal, and educational bar-
riers to opioid availability; and (2) lack of programs to
deliver palliative care at the community level. Because
people dying from AIDS require much the same pallia-
tive care as do cancer patients, building or adapting or-
ganizations to serve both types of patient presents a
new set of opportunities.
High Income countries should focus their efforts on in-
ternational cancer control projects and/or actions with
the following goals: (1) to build up a working network in
LMCs of training and education programs regarding pal-
liative care; (2) to develop an innovativemodel applicable
in LMCs, which includes training personnel from various
backgrounds who can deliver psychosocial services and
symptom relief interventions; and (3) to address the is-
sues around palliative care drug availability and national
policy for palliative care in LMCs.
Cancer registration
Few LMCs have accurate, recent data about their can-
cer burden or major risk factors for cancer, consistent
with generally poor vital and health statistics. Estimates
of cancer incidence and mortality by cancer type, age,
and gender have been produced for every country by the
International Agency for Research on Cancer (IARC).
These estimates are useful for setting initial priorities, but
cannot be used to track progress or to define priorities.
LMCs must agree on what areas to monitor and evalu-
ate to assess progress in health; thus common indicators
must be agreed upon and developed, based on a realis-
tic minimum package for health interventions. For this
to happen, common and standard data sets, disaggre-
gated by gender and age will have to be designed. This
will necessitate collection of common datasets across
the continents, using the same design and methodolo-
gies, in order for scientifically sound analyses and com-
parisons to be made. Efforts should be concentrated on
the improvement of the vital statistics registration sys-
tems, epidemiological surveillance, morbidity and mor-
tality registration and resource management informa-
tion systems. Health workforce monitoring should also
be an integral part of the information system12.
Cancer registries that record cancer cases and out-
comes over time — in specific hospitals (clinical reg-
istries), or more usefully, in defined geographic areas
(population-based registries)— are important for under-
standing local cancer patterns of those who seekmedical
attention. Registries require sustained commitments and
trained personnel, which aremost feasible in urban areas
where diagnosis and treatment are available.
By linking incidence data with vital status databases,
population-based cancer registries can also estimate
relative survival, an indicator for monitoring countries’
performance in cancer control5. Moreover, internation-
al comparisons of population-based cancer relative sur-
vival provide valuable information about cancer out-
comes and progress in cancer control for clinicians, pa-
tients and policy-makers66.
Training and education focusing on primary
prevention
It has recently been estimated that in Europe about
50% of the most common cancers could be avoided
through interventions directed at reducing smoking,
obesity and alcohol use, as well as increasing physical
activity and fruit and vegetable intake67. In LMCs, where
these risk factors are not yet well-known, potentially ef-
fective ways of curbing the increasing cancer burden are
to take measures to prevent cancer, such as smoking
cessation and reducing alcohol consumption, reducing
exposure to carcinogens (e.g., asbestos), persuading
people to change their eating habits and encouraging
physical activity. These prevention strategies are a real-
istic approach to cancer control plans in those LMCs
where other interventional cancer control initiatives are
limited or not yet feasible.
Current educational approaches to building interdisci-
plinary teams to address cancer control tend to be poorly
coordinated and not always useful in LMCs. The standard
model includes providing support for oncologists from
LMCs to attend major cancer meetings in high-income
countries, organizing smaller versions of suchmeetings in
LMCs, and providing training in institutions in high-in-
come countries. In each of these situations, the education-
al content largely addresses the needs of the high-income
countries and ignores obstacles blocking progress in LM-
Cs, such as those that arise from a shortage of human and
material resources, poverty, illiteracy, and a broad range of
cultural issues. Not surprisingly, a substantial fraction of
those who undergo formal training in high-income coun-
tries do not return home or do so only temporarily. Even
when LMCs themselves are able to effectively train health
professionals, many of their graduates emigrate to coun-
tries able to offer better personal and professional circum-
stances. Internal disparities compound the problem: ur-
ban regions are far better served than rural regions, and
the for-profit health-care sector, which tends to expand
side-by-side with economic development, serves a small
fraction of the population but attracts a high proportion of
the available health professionals. In these circumstances,
the development of guidelines for best-practice treatment
is problematic. Such guidelines tend to be derived largely
fromevidenceobtained inhigh-incomecountries, and the
presumption of their applicability in low-resource settings
might not always be correct.
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International efforts should be addressed to better un-
derstand the specific needs and focused on defining
more concrete projects for providing contextually ap-
propriate cancer training and education in LMCs. This
means giving priority to primary prevention, coordinat-
ing the project in cooperation with the stakeholders in
LMCs. and developing centers of excellence in education
and training for ongoing skills development in LMCs.
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